Part 3/3. Biopharm aspects of new modalities including biologics Sweden has been a strong player in the field of inhaled medicines for several decades, especially regarding medicines for asthma and COPD. This seminar series initiates the discussion around other, poorly treated lung diseases. The third seminar has a focus on biopharm aspects, and covers inhaled […]